<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Rieken Macedoprmrocco@biof.ufrj.bra2CruzFernanda Ferreiraffcruz@biof.ufrj.bra*2[a], [b], [c], â�ŽCorresponding author at: Laboratory of" exact="Pulmonary" post="Investigation, Carlos Chagas Filho Biophysics Institute, Federal University of"/>
 <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
 <result pre="â€¢COVID-19 is associated with cytokine storm, and eventually related to" exact="septic shock" post="and ARDS. â€¢Steroids are discouraged for use in viral"/>
 <result pre="septic shock and ARDS. â€¢Steroids are discouraged for use in" exact="viral" post="lung infections, including COVID-19, with exceptions. â€¢Corticosteroids are indicated"/>
 <result pre="COVID-19, with exceptions. â€¢Corticosteroids are indicated for adults with refractory" exact="septic shock" post="and moderate and severe ARDS. â€¢Steroids are indicated for"/>
 <result pre="moderate and severe ARDS. â€¢Steroids are indicated for management of" exact="asthma" post="and chronic obstructive pulmonary disease exacerbation. â€¢Steroids reduced mortality"/>
 <result pre="severe ARDS. â€¢Steroids are indicated for management of asthma and" exact="chronic" post="obstructive pulmonary disease exacerbation. â€¢Steroids reduced mortality in COVID-19"/>
 <result pre="â€¢Steroids are indicated for management of asthma and chronic obstructive" exact="pulmonary" post="disease exacerbation. â€¢Steroids reduced mortality in COVID-19 patients in"/>
 <result pre="are indicated for management of asthma and chronic obstructive pulmonary" exact="disease" post="exacerbation. â€¢Steroids reduced mortality in COVID-19 patients in need"/>
 <result pre="mechanical ventilation. Abstract In December 2019, an outbreak of severe" exact="pneumonia" post="was reported in Wuhan, China. Later described as COVID-19"/>
 <result pre="was reported in Wuhan, China. Later described as COVID-19 (coronavirus" exact="disease" post="2019), this infection caused by a virus from the"/>
 <result pre="Wuhan, China. Later described as COVID-19 (coronavirus disease 2019), this" exact="infection" post="caused by a virus from the Coronaviridae family (SARS-CoV-2)"/>
 <result pre="family (SARS-CoV-2) has spread globally. Effective therapies for this new" exact="disease" post="are urgently needed. In this short communication, we will"/>
 <result pre="therapies for this new disease are urgently needed. In this" exact="short" post="communication, we will evaluate the use of corticosteroids as"/>
 <result pre="1 Introduction Steroids were commonly used during the 2002â€&quot;2004 severe" exact="acute" post="respiratory syndrome coronavirus 1 (SARS-CoV-1) outbreak, in addition to"/>
 <result pre="Introduction Steroids were commonly used during the 2002â€&quot;2004 severe acute" exact="respiratory" post="syndrome coronavirus 1 (SARS-CoV-1) outbreak, in addition to other"/>
 <result pre="Steroids were commonly used during the 2002â€&quot;2004 severe acute respiratory" exact="syndrome" post="coronavirus 1 (SARS-CoV-1) outbreak, in addition to other drugs,"/>
 <result pre="being administered in many centers for the treatment of coronavirus" exact="disease" post="(COVID)-19 caused by SARS-CoV-2 (World Health Organization (WHO, 2020),"/>
 <result pre="corticosteroids in management of COVID-19 is becoming available. In this" exact="short" post="communication, we will discuss the recent literature regarding the"/>
 <result pre="Pros Steroids have been used as an adjuvant therapy for" exact="septic shock," post="especially when adequate fluid resuscitation and treatment with vasopressors"/>
 <result pre="resuscitation and treatment with vasopressors are unable to stabilize hemodynamics." exact="Viral" post="infections can lead to a hyperinflammatory state, in which"/>
 <result pre="and treatment with vasopressors are unable to stabilize hemodynamics. Viral" exact="infections" post="can lead to a hyperinflammatory state, in which the"/>
 <result pre="response (Lam et al., 2004). In 2003, patients with SARS-CoV-1" exact="infection" post="showed elevated levels of T-helper lymphocyte type 1 (Th1)"/>
 <result pre="patients with SARS-CoV-1 infection showed elevated levels of T-helper lymphocyte" exact="type 1" post="(Th1) cytokine interferon (IFN)-Î³, Th1 chemokine IFN-Î³-inducible protein-10 (IP-10),"/>
 <result pre="protein-10 (IP-10), proinflammatory cytokines interleukin (IL)-1Î², IL-6, IL-8, IL-12, and" exact="monocyte" post="chemoattractant protein (MCP)-1 for at least 2 weeks after"/>
 <result pre="of mitigating the cytokine storm caused by SARS-CoV-2 and reducing" exact="peripheral" post="vasodilation (Alhazzani et al., 2020). Fig. 1 Modulation of"/>
 <result pre="inflammatory response by corticosteroids. Corticosteroids reduce IL-8, interleukin 8; MCP-1," exact="monocyte" post="chemoattractant protein 1; and IP-10, interferon-Î³-inducible protein 10. Moreover,"/>
 <result pre="not require supplemental oxygen at admission (Horby et al., 2020)." exact="Complete" post="analyses of this study are pending, and peer review"/>
 <result pre="to recommend that dexamethasone be administered to COVID-19-patients with hypoxemic" exact="respiratory" post="failure (World Health Organization (WHO, 2020). In a recent"/>
 <result pre="(World Health Organization (WHO, 2020). In a recent guideline, the" exact="Infectious" post="Diseases Society of America (IDSA) recommended against the use"/>
 <result pre="Health Organization (WHO, 2020). In a recent guideline, the Infectious" exact="Diseases" post="Society of America (IDSA) recommended against the use of"/>
 <result pre="data have shown discouraging outcomes when steroids are used in" exact="viral" post="lung infections. Evidence from observational studies suggests a higher"/>
 <result pre="a higher mortality rate when steroids are used in influenza-induced" exact="acute" post="lung injury. A recent meta-analysis of 10 studies enrolling"/>
 <result pre="lung injury. A recent meta-analysis of 10 studies enrolling a" exact="total" post="of 6548 patients reported that the use of steroids"/>
 <result pre="mortality and length of ICU stay in patients with influenza" exact="pneumonia" post="(Ni et al., 2019); this effect could be due"/>
 <result pre="to prolonged viremia, as well as to increased risk of" exact="bacterial" post="superinfection. Moreover, steroids may increase the risk of developing"/>
 <result pre="superinfection. Moreover, steroids may increase the risk of developing other" exact="systemic" post="complications, such as autoimmune and cardiovascular events, and can"/>
 <result pre="increase the risk of developing other systemic complications, such as" exact="autoimmune" post="and cardiovascular events, and can promote resistance to neuromuscular"/>
 <result pre="risk of developing other systemic complications, such as autoimmune and" exact="cardiovascular" post="events, and can promote resistance to neuromuscular blocking agents,"/>
 <result pre="al., 2006). Additionally, high-dose of steroid therapy was associated with" exact="diabetes" post="and with SARS-related psychosis. A study of 30 patients"/>
 <result pre="with SARS-related psychosis. A study of 30 patients with SARS-CoV-1" exact="infection" post="treated with methylprednisolone showed that the initial stage of"/>
 <result pre="treated with methylprednisolone showed that the initial stage of the" exact="disease" post="is characterized by a reduction of CD4+, CD8+, and"/>
 <result pre="the administration of high-dose steroids, increasing the risk of serious" exact="secondary" post="infections. Finally, in a study of SARS-CoV-1 patients in"/>
 <result pre="placebo, suggested that corticosteroid administration could be associated with increased" exact="viral" post="load in plasma of patients who had received the"/>
 <result pre="to placebo group (Stockman et al., 2006). Similarly, Middle East" exact="respiratory" post="syndrome (MERS)-CoV patients treated with steroids appeared to experience"/>
 <result pre="placebo group (Stockman et al., 2006). Similarly, Middle East respiratory" exact="syndrome" post="(MERS)-CoV patients treated with steroids appeared to experience worse"/>
 <result pre="experience worse outcomes than those not given steroids, including sustained" exact="viral" post="replication, increased need for mechanical ventilation, vasoconstrictors, and renal"/>
 <result pre="and the steadily increasing number of infected patients, the Chinese" exact="Thoracic" post="Society (CTS) released an expert consensus on the use"/>
 <result pre="due to underlying diseases or who regularly use steroids for" exact="chronic" post="diseases; and (iv) the dose administered should be low"/>
 <result pre="low to moderate (â‰¤0.5âˆ’1â€‰mg/kg/day methylprednisolone or equivalent), and the duration" exact="short" post="(â‰¤7 days). Additionally, CTS experts recommend against the indiscriminate"/>
 <result pre="retention, hypertension, psychological effects, weight gain, or increased risk of" exact="infections" post="and osteoporosis. Also, clinicians should be aware of possible"/>
 <result pre="be avoided, except in specific cases such as management of" exact="asthma" post="and chronic obstructive pulmonary disease exacerbation; septic shock; ARDS;"/>
 <result pre="except in specific cases such as management of asthma and" exact="chronic" post="obstructive pulmonary disease exacerbation; septic shock; ARDS; and acute"/>
 <result pre="specific cases such as management of asthma and chronic obstructive" exact="pulmonary" post="disease exacerbation; septic shock; ARDS; and acute respiratory failure"/>
 <result pre="cases such as management of asthma and chronic obstructive pulmonary" exact="disease" post="exacerbation; septic shock; ARDS; and acute respiratory failure (World"/>
 <result pre="as management of asthma and chronic obstructive pulmonary disease exacerbation;" exact="septic shock;" post="ARDS; and acute respiratory failure (World Health Organization (WHO,"/>
 <result pre="and chronic obstructive pulmonary disease exacerbation; septic shock; ARDS; and" exact="acute" post="respiratory failure (World Health Organization (WHO, 2020). Further well-designed"/>
 <result pre="chronic obstructive pulmonary disease exacerbation; septic shock; ARDS; and acute" exact="respiratory" post="failure (World Health Organization (WHO, 2020). Further well-designed clinical"/>
 <result pre="de Janeiro State Research Foundation, Rio de Janeiro, Brazil; the" exact="Brazilian" post="Council for Scientific and Technological Development (CNPq), BrasÃ­lia, Brazil;"/>
 <result pre="(CAPES), BrasÃ­lia, Brazil; Department of Science and Technology (DECIT) â€&quot;" exact="Brazilian" post="Ministry of Health; and the National Institute of Science"/>
 <result pre="guidelines on the management of critically ill adults with Coronavirus" exact="Disease" post="2019 (COVID-19)Intensive Care Med.46202085488732222812 ArabiY.M.MandourahY.Al-HameedF.SindiA.A.AlmekhlafiG.A.HusseinM.A.JoseJ.PintoR.Al-OmariA.KharabaA.AlmotairiA.Al KhatibK.AlraddadiB.ShalhoubS.AbdulmomenA.QushmaqI.MadyA.SolaimanO.Al-AithanA.M.Al-RaddadiR.RagabA.BalkhyH.H.Al HarthyA.DeebA.M.Al MutairiH.Al-DawoodA.MersonL.HaydenF.G.FowlerR.A.Saudi Critical"/>
 <result pre="Trial GroupCorticosteroid therapy for critically ill patients with middle east" exact="respiratory" post="syndromeAm. J. Respir. Crit. Care Med.197201875776729161116 BhimrajA.MorganL.R.LShumakerA.H.LavergneV.BadenL.ChengV.C.EdwardsK.M.GandhiR.MullerW.J.Oâ€™HoroJ.O.ShohamS.MuradM.H.MustafaR.A.SultanS.Falck-YtterY.Infectious Diseases Society"/>
 <result pre="middle east respiratory syndromeAm. J. Respir. Crit. Care Med.197201875776729161116 BhimrajA.MorganL.R.LShumakerA.H.LavergneV.BadenL.ChengV.C.EdwardsK.M.GandhiR.MullerW.J.Oâ€™HoroJ.O.ShohamS.MuradM.H.MustafaR.A.SultanS.Falck-YtterY.Infectious" exact="Diseases" post="Society of America Guidelines on the Treatment and Management"/>
 <result pre="Hospitalized Patients With COVID-19: Preliminary Report202010.1101/2020.06.22.20137273published online June 22 LamC.W.ChanM.H.WongC.K.Severe" exact="acute" post="respiratory syndrome: clinical and laboratory manifestationsClin. Biochem. Rev.25200412113218458712 NiY.N.ChenG.SunJ.LiangB.M.LiangZ.A.The"/>
 <result pre="Patients With COVID-19: Preliminary Report202010.1101/2020.06.22.20137273published online June 22 LamC.W.ChanM.H.WongC.K.Severe acute" exact="respiratory" post="syndrome: clinical and laboratory manifestationsClin. Biochem. Rev.25200412113218458712 NiY.N.ChenG.SunJ.LiangB.M.LiangZ.A.The effect"/>
 <result pre="with COVID-19 pneumoniaSig. Transduct. Target Ther.57202010.1038/s41392-020-0158-2 World Health Organization (WHO)Coronavirus" exact="Disease" post="(COVID-19) Situation Dashboard2020(Accessed June 28, 2020)https://www.who.int/emergencies/diseases/novel-coronavirus-2019 Acknowledgements We express"/>
</results>
